Technology 

Midkine is a novel therapeutic and diagnostic target
 
Midkine structure and action 

Midkine is a small two domain protein prevalent during embryonic development. It acts as a modulator in many interactions controlling cell growth, cell spread and cell adherence properties, interactions which are of relevance to nerve growth and repair, cancer, wound healing, and inflammation.  

Midkine is not detectable in healthy adults and only re-appears in the body as part of the pathogenesis of diseases. Accordingly,  midkine is an important novel target for the treatment of certain conditions including inflammatory and autoimmune diseases as well as a number of solid tumors and carcinomas.  

 

© Cellmid Ltd
Web Developer Sydney
Web design company
Cellmid Ltd   ABN 69 111 304 119   T: +61 2 9299 0311   E: info@cellmid.com.au